These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37095586)

  • 21. Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer.
    Jain P; Khorrami M; Gupta A; Rajiah P; Bera K; Viswanathan VS; Fu P; Dowlati A; Madabhushi A
    Front Oncol; 2021; 11():744724. PubMed ID: 34745966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 23. Computed Tomography-Based Radiomics in Predicting T Stage and Length of Esophageal Squamous Cell Carcinoma.
    Yang M; Hu P; Li M; Ding R; Wang Y; Pan S; Kang M; Kong W; Du D; Wang F
    Front Oncol; 2021; 11():722961. PubMed ID: 34722265
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
    Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT radiomics features to predict lymph node metastasis in advanced esophageal squamous cell carcinoma and to discriminate between regional and non-regional lymph node metastasis: a case control study.
    Ou J; Wu L; Li R; Wu CQ; Liu J; Chen TW; Zhang XM; Tang S; Wu YP; Yang LQ; Tan BG; Lu FL
    Quant Imaging Med Surg; 2021 Feb; 11(2):628-640. PubMed ID: 33532263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072).
    Liu W; Zeng C; Wang S; Zhan Y; Huang R; Luo T; Peng G; Wu Y; Qiu Z; Li D; Wu F; Chen C
    Front Oncol; 2022; 12():1026305. PubMed ID: 37078004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Nomogram Model Based on Cone-Beam CT Radiomics Analysis Technology for Predicting Radiation Pneumonitis in Esophageal Cancer Patients Undergoing Radiotherapy.
    Du F; Tang N; Cui Y; Wang W; Zhang Y; Li Z; Li J
    Front Oncol; 2020; 10():596013. PubMed ID: 33392091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of computed tomography radiomics combined with inflammation indices in predicting the efficacy of immunotherapy in patients with locally advanced and metastatic non-small cell lung cancer.
    Shao H; Zhu J; Shi L; Yao J; Wang Y; Ma C; Swierniak A; Ni B
    J Thorac Dis; 2024 May; 16(5):3213-3227. PubMed ID: 38883654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
    Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
    Front Oncol; 2022; 12():843991. PubMed ID: 35692757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.
    Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W; Chen X
    Front Nutr; 2022; 9():896847. PubMed ID: 35990358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
    Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
    BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of contrast-enhanced magnetic resonance imaging-T2WI-based radiomic features in distinguishing lung adenocarcinoma from lung squamous cell carcinoma with solid components >8 mm.
    Yang M; Shi L; Huang T; Li G; Shao H; Shen Y; Zhu J; Ni B
    J Thorac Dis; 2023 Feb; 15(2):635-648. PubMed ID: 36910079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
    Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
    Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
    Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
    Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a radiomics-based nomogram for the prediction of postoperative malnutrition in stage IB1-IIA2 cervical carcinoma.
    Yu W; Xu H; Chen F; Shou H; Chen Y; Jia Y; Zhang H; Ding J; Xiong H; Wang Y; Song T
    Front Nutr; 2023; 10():1113588. PubMed ID: 36819703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 38. CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
    Yang Z; He B; Zhuang X; Gao X; Wang D; Li M; Lin Z; Luo R
    J Radiat Res; 2019 Jul; 60(4):538-545. PubMed ID: 31111948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of
    Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
    Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
    Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
    J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.